Singota: Faster From Formulation To Fill/Finish

Navigating the complexities of drug development and aseptic fill/finish processes demands a partner who prioritizes agility and responsiveness. At Singota Solutions (Bloomington, Indiana CDMO), we understand the challenges faced by small batch aseptic manufacturing solutions and early phase partners in meeting tight timelines and unique formulation requirements. Our focus on…

Transitioning From Academic Research To Pharmaceutical Industry Drug Formulation And Analytical Development

Embarking on a career transition from academic research to industry demands a nuanced understanding of the diverse demands and objectives shaping each realm. At Singota Solutions (Bloomington, Indiana CDMO), we recognize the challenges and opportunities inherent in this shift, particularly in the realm of injectable formulation development. In this article,…

Challenges and Solutions in Biologic Therapies Product Manufacturing

In the intricate realm of injectable formulation development, crafting effective solutions for biologic therapies demands meticulous attention to detail and innovative approaches. Unlike conventional small molecule products, biologics necessitate specialized small batch aseptic filler techniques (Singota Solution's specialty) tailored to their unique properties and parenteral administration requirements. Formulation scientists and…

Advancing Aseptic Filling: Evaluating The Revolutionary SA25 Workcell

In the ever-evolving landscape of injectable formulation development, aseptic filling, and aseptic manufacturing solutions, the SA25 Workcell, a groundbreaking innovation crafted by Vanrx (now Cytiva) that Singota Solution's (CDMO in Bloomington, Indiana) pioneered in North America, emerges as a beacon of progress. This state-of-the-art technology represents a significant leap in…

Captisol®: What gives EuropeanPharmacopeia?!

Analytical Method Challenges for EP Monograph, Captisol ® At the 2023 American Drug Delivery and Formulation Summit, Ryan Memmer from Singota Solutions (leading CDMO in Bloomington, Indiana), captivated the audience with his insightful presentation on "Analytical Method Challenges for EP Monograph," titled "Captisol®: What gives European Pharmacopeia?!" Memmer's expertise in…

Specializing In Small And Early-Stage Injectables, Not Just Small Batches

Source: Singota Solutions Navigating the complex landscape of pharmaceutical development (Injectables), particularly for small and early-stage companies, demands careful consideration of manufacturing partnerships. While large CDMOs may seem like obvious choices, their focus on high-volume production often leaves smaller projects sidelined. This shift is notable in the context of the industry's…

Posts pagination